Search

Pliant Therapeutics Inc

Fechado

0.9 2.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.87

Máximo

0.92

Indicadores-chave

By Trading Economics

Rendimento

-2.3M

-22M

EPS

-0.36

Funcionários

49

EBITDA

-2.3M

-22M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+178.09% upside

Dividendos

By Acuity

Próximos Ganhos

12 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.3M

61M

Abertura anterior

-1.37

Fecho anterior

0.9

Pliant Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de out. de 2026, 23:56 UTC

AxoGen Inc is trading modestly lower in after-market hours, retracing from a brief rally that peaked above Monday's close.

19 de out. de 2026, 23:56 UTC

Sabre Corp shares advanced in after-market trading, recovering from earlier lows after a week-long decline, with a higher cumulative return.

19 de out. de 2026, 23:56 UTC

Royal Gold Inc is trading modestly higher in after-market hours, fluctuating around the middle of its one-month range without significant excursions.

19 de out. de 2026, 23:56 UTC

Axsome Therapeutics Inc shares are trading higher in after-market hours, having pulled back from an initial gain shortly after the market closed.

19 de out. de 2026, 23:56 UTC

CVR Energy Inc is trading higher in after-market hours, maintaining a steady position above its 20-day moving average since Monday's close.

19 de out. de 2026, 23:56 UTC

Jack Henry & Associates Inc is down in after-market trading, having pulled back from a session low earlier.

19 de out. de 2026, 23:56 UTC

Cognex Corp shares advanced modestly in after-market hours, recovering from a prior decline, but remain below their 20-day moving average.

19 de out. de 2026, 23:56 UTC

Hercules Capital Inc is trading lower in after-market hours, retreating to nearly the low end of its range since Monday's close.

19 de out. de 2026, 23:56 UTC

TE Connectivity PLC has advanced in after-market trading, reaching its highest point of the day after initially dipping following Monday's close.

19 de out. de 2026, 23:56 UTC

Cheesecake Factory Inc shares are trading modestly lower in after-market hours, retracing from an early high following a decline since Monday's close.

19 de out. de 2026, 23:56 UTC

Scholar Rock Holding Corp is trading higher in after-market hours, reaching a peak return shortly after the market reopened.

19 de out. de 2026, 23:56 UTC

Kroger Co shares are trading modestly higher in after-market hours, reaching their highest level since Monday's close and above the 20-day moving average.

19 de out. de 2026, 23:56 UTC

News

JP Morgan maintains Overweight rating on First Solar while lowering price target to $252, reflecting ongoing confidence in the company's future.

19 de out. de 2026, 23:56 UTC

Campbell's Co shares advanced modestly in after-market trading, maintaining stability and peaking before slightly retracing within the one-month trading range.

19 de out. de 2026, 23:53 UTC

PDD Holdings Inc. is advancing in after-market trading, reaching its highest level since Monday's close and remaining above its 20-day moving average.

19 de out. de 2026, 23:52 UTC

DraftKings Inc shares are trading modestly lower in after-market hours, remaining below Monday's close and near the lowest point of the day.

19 de out. de 2026, 23:51 UTC

Tootsie Roll Industries Inc shares advanced in after-market trading on Monday, recovering from earlier lows to a higher return by the latest observation.

19 de out. de 2026, 23:51 UTC

HealthStream Inc. is trading modestly lower in after-market hours, having retraced from a brief peak earlier in the session.

19 de out. de 2026, 23:51 UTC

Macy's Inc shares are trading modestly higher in after-market hours, recovering from earlier lows and positioned above its 20-day moving average.

19 de out. de 2026, 23:51 UTC

Tyson Foods Inc shares advanced modestly in after-market trading, remaining strong above the 20-day moving average and near the upper end of its one-month range.

19 de out. de 2026, 23:51 UTC

AMETEK Inc's shares advanced modestly in after-market trading, recovering from an initial dip and positioning around the middle of its one-month trading range.

19 de out. de 2026, 23:51 UTC

Social Media

Netflix Inc shares traded modestly lower during after-market hours on Monday, following the recent firing of its Chief Content Officer and film chief.

19 de out. de 2026, 23:51 UTC

Community Financial System Inc shares declined during after-market hours on Monday, reversing a trend of higher daily closes observed since last week.

19 de out. de 2026, 23:51 UTC

SentinelOne Inc shares advanced modestly in after-market hours, reaching a peak cumulative return since Monday's close, though still below its 20-day moving average.

19 de out. de 2026, 23:51 UTC

Event
News

Bristol-Myers Squibb announces BioNTech SE will present new clinical data at the ESMO 2026 Congress, featuring 16 abstracts on various tumor types.

19 de out. de 2026, 23:51 UTC

Zoetis Inc shares traded modestly lower in after-market hours, following a notable decline that has continued since Monday's close.

19 de out. de 2026, 23:51 UTC

U.S. Initial Jobless Claims Expected at 200K Amid Resilient Labor Market and Cautious Optimism in Financial Markets

19 de out. de 2026, 23:51 UTC

Pending Home Sales Expected to Decline 0.5% Amid Rising Mortgage Rates and Decreased Buyer Demand, Signaling Ongoing Challenges in Housing Market

19 de out. de 2026, 23:51 UTC

Pending Home Sales Data Release Expected to Reflect Decline Amid Rising Mortgage Rates and Affordability Concerns

19 de out. de 2026, 23:51 UTC

News

ServisFirst Bancshares reports Q3 earnings of $0.80 per share and revenue of $172.9 million, both below analyst expectations, contributing to a decline in after-market trading.

Comparação entre Pares

Variação de preço

Pliant Therapeutics Inc Previsão

Preço-alvo

By TipRanks

178.09% parte superior

Previsão para 12 meses

Média 2.5 USD  178.09%

Máximo 3 USD

Mínimo 2 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Pliant Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

0

Comprar

4

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
help-icon Live chat